Cite
HARVARD Citation
Du, Y. et al. (2023). A multicentre, randomized, double‐blind, parallel, active‐ and placebo‐controlled Phase 3 clinical study of the glucokinase activator PB‐201 in treatment‐naive patients with type 2 diabetes mellitus: A study protocol. Diabetes, obesity & metabolism. 25 (3), pp. 649-655. [Online].